Article Figures & Tables
Tables
- Table 1:
Total public drug program spending overall and for high–drug-cost beneficiaries* in Canada (excluding Quebec and territories), 2016/17
Province Overall High–drug-cost beneficiaries Total program spending, $ millions Mean cost per beneficiary, $ Total program spending, $ millions % of program spending Minimum cost threshold, $ Mean cost per beneficiary, $ Overall 8185.0 1570 3809.0 46.5 5291 14 610 British Columbia 1087.2 1473 586.6 54.0 5319 15 896 Alberta 773.3 1330 363.5 47.0 3791 12 502 Saskatchewan 316.7 1106 175.5 55.4 3940 12 253 Manitoba 320.8 2347 174.7 54.5 8567 25 560 Ontario 5126.3 1673 2242.6 43.7 5656 14 640 New Brunswick 210.9 1662 93.5 44.3 5408 14 744 Nova Scotia 187.0 1369 76.3 40.8 4065 11 175 Prince Edward Island 26.0 632 13.7 52.6 2282 6650 Newfoundland and Labrador 136.8 1326 56.0 41.0 4397 10 863 ↵* Defined as the top 5% of beneficiaries based on annual costs.
- Table 2:
Drug use by high–drug-cost beneficiaries and other beneficiaries
Province High–drug-cost beneficiaries Other beneficiaries No. of drugs, median (IQR) % with claim > $1000 % aged ≥65 yr No. of drugs, median (IQR) % with claim > $1000 % aged ≥65 yr Overall 13 (7–19) 40.9 48.2 8 (4–13) 0.6 65.1 British Columbia 8 (5–14) 38.0 26.1 4 (2–7) 0.6 45.6 Alberta 13 (8–18) 38.4 66.0 6 (3–9) 0.3 81.2 Saskatchewan 12 (7–18) 22.1 39.3 3 (1–6) 0.1 45.4 Manitoba 9 (5–15) 63.4 23.4 6 (3–10) 1.0 40.5 Ontario 14 (8–19) 44.4 54.9 6 (3–10) 0.7 71.5 New Brunswick 11 (6–17) 37.2 34.6 6 (3–10) 0.6 63.4 Nova Scotia 16 (12–21) 16.5 81.5 6 (4–10) 0.2 88.0 Prince Edward Island 12 (8–16) 4.8 41.7 4 (2–6) 0.0 62.3 Newfoundland and Labrador 16 (9–22) 15.3 38.3 6 (3–10) 0.2 50.3 Note: IQR = interquartile range.
- Table 3:
Total public drug program spending overall and for beneficiaries with very high drug costs*
Province Overall total program spending, $ millions Beneficiaries with very high drug costs Total program spending, $ millions % of total program spending Minimum cost threshold, $ Average cost, $ Overall 8185.0 1906.0 23.3 18 831 36 553 British Columbia 1087.2 297.8 27.4 19 890 40 345 Alberta 773.3 189.3 24.5 19 590 32 545 Saskatchewan 316.7 89.7 28.3 17 888 31 319 Manitoba 320.8 85.5 26.6 30 978 62 520 Ontario 5126.3 1107.5 21.6 18 073 36 144 New Brunswick 210.9 44.2 21.0 20 442 34 822 Nova Scotia 187.0 42.2 22.6 15 606 30 882 Prince Edward Island 26.0 7.6 29.2 7932 18 465 Newfoundland and Labrador 136.8 29.1 21.3 13 386 28 161 ↵* Defined as the top 1% of beneficiaries based on annual costs.
- Table 4:
Ten most costly and 10 most commonly reimbursed medications, by cost category of beneficiaries
Rank Beneficiaries with very high drug-costs High–drug-cost beneficiaries Other beneficiaries Drug name No. of users Drug name No. of users Drug name No. of users Total spending 1 Infliximab* 331 002 170 Ranibizumab* 149 319 608 Salmeterol/ fluticasone 110 037 629 2 Sofosbuvir/ledipasvir† 270 669 622 Aflibercept 122 412 063 Atorvastatin 108 457 147 3 Adalimumab* 145 652 072 Adalimumab* 82 784 426 Perindopril 91 622 949 4 Lenalidomide 118 550 630 Paliperidone 62 288 410 Rosuvastatin 86 933 263 5 Etanercept* 86 154 466 Etanercept 50 613 266 Metformin/ sitagliptin 83 201 111 6 Sofosbuvir† 74 950 373 Insulin glargine 38 740 800 Sitagliptin 76 710 532 7 Ranibizumab* 65 440 527 Infliximab* 37 537 419 Methadone 76 477 878 8 Aflibercept 52 468 572 Hydromorphone 36 425 150 Rivaroxaban 75 651 662 9 Eculizumab* 37 516 433 Aripiprazole 34 064 003 Insulin glargine 74 519 810 10 Dasabuvir/ombitasvir/ paritaprevir/ritonavir† 36 048 600 Methadone 28 115 644 Pantoprazole 72 636 566 Total use 1 Pantoprazole 10 090 Pantoprazole 56 988 Rosuvastatin 894 699 2 Infliximab* 9645 Salbutamol 55 470 Atorvastatin 785 322 3 Salbutamol 9104 Rosuvastatin 44,517 Pantoprazole 733 233 4 Codeine/ acetaminophen 7524 Atorvastatin 43 747 Amoxicillin 723 256 5 Prednisone 7308 Metformin 43 583 Levothyroxine 705 881 6 Amoxicillin 7274 Furosemide 41 962 Salbutamol 646 392 7 Rosuvastatin 7072 Amlodipine 36 877 Amlodipine 632 970 8 Adalimumab* 6549 Levothyroxine 36 700 Metformin 599 120 9 Methotrexate 6277 Amoxicillin 34 237 Codeine/ acetaminophen 531 586 10 Levothyroxine 6228 Codeine/ acetaminophen 34 045 Ramipril 473 130